Guest Editor
(Source: Diabetes Spectrum)
Source: Diabetes Spectrum - November 14, 2016 Category: Endocrinology Tags: From Research to Practice Source Type: research

Cognition and Diabetes Across the Life Span: Preface
(Source: Diabetes Spectrum)
Source: Diabetes Spectrum - November 14, 2016 Category: Endocrinology Authors: Chaytor, N. Tags: From Research to Practice Source Type: research

Erratum: Mystkowski P, Neumiller JJ. Prandial Insulin Dosing: How Long Does It Take to Go 80 Miles? Diabetes Spectrum 2016;29:67-69 (DOI:10.2337/diaspect.29.2.67)
(Source: Diabetes Spectrum)
Source: Diabetes Spectrum - August 14, 2016 Category: Endocrinology Tags: Errata Source Type: research

Erratum: Blum AK. Insulin Use in Pregnancy: An Update. Diabetes Spectrum 2016;29:92-97 (DOI:10.2337/diaspect.29.2.92)
(Source: Diabetes Spectrum)
Source: Diabetes Spectrum - August 14, 2016 Category: Endocrinology Tags: Errata Source Type: research

Cultural Differences and Considerations When Initiating Insulin
(Source: Diabetes Spectrum)
Source: Diabetes Spectrum - August 14, 2016 Category: Endocrinology Authors: Rebolledo, J. A.; Arellano, R. Tags: Lifestyle and Behavior Source Type: research

Commentary: Why Was Inhaled Insulin a Failure in the Market?
(Source: Diabetes Spectrum)
Source: Diabetes Spectrum - August 14, 2016 Category: Endocrinology Authors: Oleck, J.; Kassam, S.; Goldman, J. D. Tags: Pharmacy and Therapeutics Source Type: research

A Novel Approach to the Management of Neonatal Diabetes Using Sensor-Augmented Insulin Pump Therapy With Threshold Suspend Technology at Diagnosis
(Source: Diabetes Spectrum)
Source: Diabetes Spectrum - August 14, 2016 Category: Endocrinology Authors: Marin, M. T.; Coffey, M. L.; Beck, J. K.; Dasari, P. S.; Allen, R.; Krishnan, S. Tags: Care Innovations Source Type: research

What the Latest Evidence Tells Us About Fat and Cardiovascular Health
(Source: Diabetes Spectrum)
Source: Diabetes Spectrum - August 14, 2016 Category: Endocrinology Authors: Hayes, J.; Benson, G. Tags: Nutrition FYI Source Type: research

Adherence to Insulin Therapy
IN BRIEF Six million people with diabetes use insulin either alone or in combination with an oral medication. Many barriers exist that lead to poor adherence with insulin. However, there is an underwhelming amount of data on interventions to address these barriers and improve insulin adherence. Until pharmacological advancements create easier, more acceptable insulin regimens, it is imperative to involve patients in shared decision-making. (Source: Diabetes Spectrum)
Source: Diabetes Spectrum - August 14, 2016 Category: Endocrinology Authors: Sarbacker, G. B.; Urteaga, E. M. Tags: From Research to Practice Source Type: research

The Future of Biosimilar Insulins
IN BRIEF Biosimilar insulins are available in many countries and will be made available in the United States in the near future. Some concerns associated with biosimilar insulins include potential differences in the efficacy and safety between a biosimilar product and its reference insulin, the ramifications of having the same name or different names for a biosimilar and its reference insulin, the prospects of and limitations to substituting insulin products, and the proper implementation of pharmacovigilance. Still, health care providers will have the opportunity, with continued appropriate monitoring, to offer alternativ...
Source: Diabetes Spectrum - August 14, 2016 Category: Endocrinology Authors: Kim, A. P.; Bindler, R. J. Tags: From Research to Practice Source Type: research

Basal Insulin Use With GLP-1 Receptor Agonists
IN BRIEF The combination of basal insulin and a glucagon-like peptide 1 receptor agonist is becoming increasingly common and offers several potential benefits to patients with type 2 diabetes. Clinical studies have demonstrated improved glycemic control and low risks of hypoglycemia and weight gain with the combination, which provides a safe and effective alternative to basal-bolus insulin with less treatment burden. Fixed-ratio combination products that administer both agents in a single injection are in the pipeline and will offer additional options for clinicians and patients. This review focuses on the rationale for, c...
Source: Diabetes Spectrum - August 14, 2016 Category: Endocrinology Authors: Anderson, S. L.; Trujillo, J. M. Tags: From Research to Practice Source Type: research

Challenges With Insulin in the Inpatient Setting
This article reviews potential challenges to and necessary considerations for ensuring the safe and effective use of insulin in the hospital setting. It offers practical suggestions for managing insulin-related issues regarding medication reconciliation, general inpatient management, and the use of concentrated insulin products. (Source: Diabetes Spectrum)
Source: Diabetes Spectrum - August 14, 2016 Category: Endocrinology Authors: Kolanczyk, D. M.; Dobersztyn, R. C. Tags: From Research to Practice Source Type: research

Embracing the Insulin Revolution in the Ambulatory Care Setting
IN BRIEF Recent additions of various new formulations of insulin to the U.S. marketplace have increased the number of treatment options available to people living with diabetes. However, it is important to take into consideration the implications of these new insulins in terms of patient safety and medication errors, integration with electronic medical records, and financial considerations. This review outlines several considerations for practitioners regarding the implications of these new insulin products for ambulatory care practice. (Source: Diabetes Spectrum)
Source: Diabetes Spectrum - August 14, 2016 Category: Endocrinology Authors: Bzowyckyj, A. S. Tags: From Research to Practice Source Type: research

An Overview of Concentrated Insulin Products
This article provides a summary of the use of available concentrated insulins in the outpatient treatment of patients with diabetes. Concentrated insulins work through the same mechanisms as other insulin products. They vary from each other in concentrations and pharmacokinetic/pharmacodynamics profiles but are each similar to their U-100 concentration counterparts. Patient education is important to minimize errors and the risk of hypoglycemia when using these insulin formulations. (Source: Diabetes Spectrum)
Source: Diabetes Spectrum - August 14, 2016 Category: Endocrinology Authors: Painter, N. A.; Sisson, E. Tags: From Research to Practice Source Type: research

Guest Editor
(Source: Diabetes Spectrum)
Source: Diabetes Spectrum - August 14, 2016 Category: Endocrinology Tags: From Research to Practice Source Type: research